Biora Therapeutics Inc (BIOR)

Finanzdaten der Biora Therapeutics Inc-Aktie (BIOR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.542	-	-	0.002	0.002
Operating Expenses	20.34% 16.06	13.34	23.32	14.94	15.55
Interest Income/Expense	49.84% 2.757	1.84	2.592	2.703	2.68
Benefits Costs and Expenses	70.22% 4.683	15.73	73.45	17.80	17.44
Costs And Expenses	70.22% 4.683	15.73	73.45	17.80	17.44
Depreciation and Amortization	10.26% 0.105	0.117	0.125	0.166	0.147
Operating Income/Loss	16.28% -15.52	-13.34	-23.32	-14.93	-15.54
Nonoperating Income/Loss	101.63% 0.217	-13.28	-52.11	-0.005	-0.081
Income/Loss From Continuing Operations Before Tax	73.67% -4.141	-15.73	-73.45	-17.80	-17.44
Income Tax Expense/Benefit	150.53% 0.048	-0.095	0.001	0.004	-
Income/Loss From Continuing Operations After Tax	73.20% -4.189	-15.63	-73.45	-17.81	-17.44
Net Income/Loss	72.82% -4.189	-15.41	-73.45	-17.81	-17.44
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	861.92% 29.30	3.0456	15.02	12.14	10.97
Diluted Average Shares	861.92% 29.30	3.0456	15.02	12.14	10.97
Basic Earnings Per Share	120.90% -0.14	0.67	-4.89	-1.47	-1.59
Diluted Earnings Per Share	120.90% -0.14	0.67	-4.89	-1.47	-1.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-